PINK:PTKFF

Pt Kalba Farma Idr Stock Earnings Reports

etoro logo Buy PTKFF
*Your capital is at risk
$0.0403
+0 (+0%)
At Close: Jun 22, 2026

PT Kalba Farma IDR Earnings Calls

Mar 31, 2026
$0.0012 (-4.80%)
Release date Apr 30, 2026
EPS estimate $0.0013
EPS actual $0.0012
EPS Surprise -4.80%
Revenue estimate 571.023M
Revenue actual 571.002M
Revenue Surprise -0.0037%
Dec 31, 2025
$0.0014 (32.69%)
Release date Mar 30, 2026
EPS estimate $0.0010
EPS actual $0.0014
EPS Surprise 32.69%
Revenue estimate 560.175M
Revenue actual 560.16M
Revenue Surprise -0.0026%
Sep 30, 2025
Release date Oct 28, 2025
EPS estimate $0.0009
EPS actual $0.0009
Revenue estimate 527.832M
Revenue actual 532.292M
Revenue Surprise 0.85%
Jun 30, 2025
$0.0012 (-2.46%)
Release date Jul 29, 2025
EPS estimate $0.0012
EPS actual $0.0012
EPS Surprise -2.46%
Revenue estimate 544.422M
Revenue actual 505.398M
Revenue Surprise -7.17%

Last 4 Quarters for PT Kalba Farma IDR

Below you can see how PTKFF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Jun 30, 2025 Missed
Release date Jul 29, 2025
Price on release $0.0930
EPS estimate $0.0012
EPS actual $0.0012
EPS surprise -2.46%
Date Price
Jul 23, 2025 $0.0930
Jul 24, 2025 $0.0930
Jul 25, 2025 $0.0751
Jul 28, 2025 $0.0930
Jul 29, 2025 $0.0930
Jul 30, 2025 $0.0930
Jul 31, 2025 $0.0930
Aug 01, 2025 $0.0958
Aug 04, 2025 $0.0958
4 days before 0%
4 days after 3.01%
On release day 0%
Change in period 3.01%
Sep 30, 2025
Release date Oct 28, 2025
Price on release $0.0802
EPS estimate $0.0009
EPS actual $0.0009
Date Price
Oct 22, 2025 $0.0643
Oct 23, 2025 $0.0643
Oct 24, 2025 $0.0626
Oct 27, 2025 $0.0643
Oct 28, 2025 $0.0802
Oct 29, 2025 $0.0802
Oct 30, 2025 $0.0802
Oct 31, 2025 $0.0626
Nov 03, 2025 $0.0802
4 days before 24.73%
4 days after 0%
On release day 0%
Change in period 24.73%
Dec 31, 2025 Beat
Release date Mar 30, 2026
Price on release $0.0590
EPS estimate $0.0010
EPS actual $0.0014
EPS surprise 32.69%
Date Price
Mar 24, 2026 $0.0590
Mar 25, 2026 $0.0590
Mar 26, 2026 $0.0590
Mar 27, 2026 $0.0590
Mar 30, 2026 $0.0590
Mar 31, 2026 $0.0590
Apr 01, 2026 $0.0590
Apr 02, 2026 $0.0590
Apr 06, 2026 $0.0590
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Mar 31, 2026 Missed
Release date Apr 30, 2026
Price on release $0.0590
EPS estimate $0.0013
EPS actual $0.0012
EPS surprise -4.80%
Date Price
Apr 24, 2026 $0.0590
Apr 27, 2026 $0.0590
Apr 28, 2026 $0.0590
Apr 29, 2026 $0.0590
Apr 30, 2026 $0.0590
May 01, 2026 $0.0535
May 04, 2026 $0.0535
May 05, 2026 $0.0535
May 06, 2026 $0.0490
4 days before 0%
4 days after -16.88%
On release day -9.33%
Change in period -16.88%

PT Kalba Farma IDR Earnings History

Earnings Calendar

FAQ

When is the earnings report for PTKFF?
PT Kalba Farma IDR (PTKFF) has scheduled its earnings report for Jul 24, 2026 after the markets close.

What is the PTKFF price-to-earnings (P/E) ratio?
PTKFF P/E ratio as of Jun 22, 2026 (TTM) is 8.53.

What is the PTKFF EPS forecast?
The forecasted EPS (Earnings Per Share) for PT Kalba Farma IDR (PTKFF) for the first fiscal quarter 2026 is $0.0011.

What are PT Kalba Farma IDR's retained earnings?
On its balance sheet, PT Kalba Farma IDR reported retained earnings of $571.00 million for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT PT KALBA FARMA IDR
PT Kalba Farma IDR
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE